Literature DB >> 23050044

Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation.

Celeste Bolin1, Ken Tawara, Caleb Sutherland, Jeff Redshaw, Patrick Aranda, Jim Moselhy, Robin Anderson, Cheryl L Jorcyk.   

Abstract

Oncostatin M (OSM) is an interleukin-6 (IL-6) family cytokine that has been implicated in a number of biological processes including inflammation, hematopoiesis, immune responses, development, and bone homeostasis. Recent evidence suggests that OSM may promote breast tumor invasion and metastasis. We investigated the role of OSM in the formation of bone metastases in vivo using the 4T1.2 mouse mammary tumor model in which OSM expression was knocked down using shRNA (4T1.2-OSM). 4T1.2-OSM cells were injected orthotopically into Balb/c mice, resulting in a greater than 97% decrease in spontaneous metastasis to bone compared to control cells. Intratibial injection of these same 4T1.2-OSM cells also dramatically reduced the osteolytic destruction of trabecular bone volume compared to control cells. Furthermore, in a tumor resection model, mice bearing 4T1.2-OSM tumors showed an increase in survival by a median of 10 days. To investigate the specific cellular mechanisms important for OSM-induced osteolytic metastasis to bone, an in vitro model was developed using the RAW 264.7 preosteoclast cell line co-cultured with 4T1.2 mouse mammary tumor cells. Treatment of co-cultures with OSM resulted in a 3-fold induction of osteoclastogenesis using the TRAP assay. We identified several tumor cell-induced factors including vascular endothelial growth factor, IL-6, and a previously uncharacterized OSM-regulated bone metastasis factor, amphiregulin (AREG), which increased osteoclast differentiation by 4.5-fold. In addition, pretreatment of co-cultures with an anti-AREG neutralizing antibody completely reversed OSM-induced osteoclastogenesis. Our results suggest that one mechanism for OSM-induced osteoclast differentiation is via an AREG autocrine loop, resulting in decreased osteoprotegerin secretion by the 4T1.2 cells. These data provide evidence that OSM might be an important therapeutic target for the prevention of breast cancer metastasis to bone.

Entities:  

Keywords:  OSM; bone metastasis; breast cancer; oncostatin M; osteoclastogenesis; osteolysis

Year:  2012        PMID: 23050044      PMCID: PMC3463924          DOI: 10.1177/1947601912458284

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  61 in total

1.  Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells.

Authors:  Hae Young Song; Eun Su Jeon; Jung Il Kim; Jin Sup Jung; Jae Ho Kim
Journal:  J Cell Biochem       Date:  2007-08-01       Impact factor: 4.429

2.  Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression.

Authors:  Marisa M Queen; Randall E Ryan; Ryan G Holzer; Cynthia R Keller-Peck; Cheryl L Jorcyk
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

3.  Bleach gel: a simple agarose gel for analyzing RNA quality.

Authors:  Patrick S Aranda; Dollie M LaJoie; Cheryl L Jorcyk
Journal:  Electrophoresis       Date:  2012-01       Impact factor: 3.535

4.  Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells.

Authors:  John C O'Connor; Mary C Farach-Carson; Charles J Schneider; Daniel D Carson
Journal:  Mol Cancer Res       Date:  2007-06       Impact factor: 5.852

5.  Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.

Authors:  Jennifer L Gilmore; Jeffrey A Scott; Zhor Bouizar; Alex Robling; Sarah E Pitfield; David J Riese; John Foley
Journal:  Breast Cancer Res Treat       Date:  2007-09-20       Impact factor: 4.872

6.  Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.

Authors:  Julio E Celis; Pavel Gromov; Teresa Cabezón; José M A Moreira; Noona Ambartsumian; Kerstin Sandelin; Fritz Rank; Irina Gromova
Journal:  Mol Cell Proteomics       Date:  2004-01-30       Impact factor: 5.911

7.  T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction.

Authors:  Silvia Colucci; Giacomina Brunetti; Rita Rizzi; Antonia Zonno; Giorgio Mori; Graziana Colaianni; Davide Del Prete; Roberta Faccio; Arcangelo Liso; Silvana Capalbo; Vincenzo Liso; Alberta Zallone; Maria Grano
Journal:  Blood       Date:  2004-08-12       Impact factor: 22.113

8.  Platelet and osteoclast beta3 integrins are critical for bone metastasis.

Authors:  Suzanne J Bakewell; Patrick Nestor; Srinivasa Prasad; Michael H Tomasson; Nikki Dowland; Mukund Mehrotra; Robert Scarborough; James Kanter; Keith Abe; David Phillips; Katherine N Weilbaecher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

Review 9.  The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer.

Authors:  Willscott E Naugler; Michael Karin
Journal:  Trends Mol Med       Date:  2008-02-07       Impact factor: 11.951

10.  Identification of RANKL in osteolytic lesions of the facial skeleton.

Authors:  J Y Y Tay; B H Bay; J F Yeo; M Harris; S Meghji; S T Dheen
Journal:  J Dent Res       Date:  2004-04       Impact factor: 6.116

View more
  38 in total

1.  Finite Element Analysis of the Mouse Distal Femur with Tumor Burden in Response to Knee Loading.

Authors:  Feifei Jiang; Shengzhi Liu; Andy Chen; Bai-Yan Li; Alexander G Robling; Jie Chen; Hiroki Yokota
Journal:  Int J Orthop (Hong Kong)       Date:  2018-02-28

2.  Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA-Sequencing.

Authors:  Ankit Mahendra; Xingyu Yang; Shaza Abnouf; Jay R T Adolacion; Daechan Park; Sanam Soomro; Jason Roszik; Cristian Coarfa; Gabrielle Romain; Keith Wanzeck; S Louis Bridges; Amita Aggarwal; Peng Qiu; Sandeep K Agarwal; Chandra Mohan; Navin Varadarajan
Journal:  Arthritis Rheumatol       Date:  2019-02-23       Impact factor: 10.995

Review 3.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

4.  Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis.

Authors:  Randall E Ryan; Bryan Martin; Liliana Mellor; Reed B Jacob; Ken Tawara; Owen M McDougal; Julia Thom Oxford; Cheryl L Jorcyk
Journal:  Cytokine       Date:  2015-01-23       Impact factor: 3.861

5.  Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.

Authors:  Emma C Walker; Rachelle W Johnson; Yifang Hu; Holly J Brennan; Ingrid J Poulton; Jian-Guo Zhang; Brendan J Jenkins; Gordon K Smyth; Nicos A Nicola; Natalie A Sims
Journal:  J Biol Chem       Date:  2016-08-18       Impact factor: 5.157

6.  Osteocyte-Driven Downregulation of Snail Restrains Effects of Drd2 Inhibitors on Mammary Tumor Cells.

Authors:  Shengzhi Liu; Yao Fan; Andy Chen; Aydin Jalali; Kazumasa Minami; Kazuhiko Ogawa; Harikrishna Nakshatri; Bai-Yan Li; Hiroki Yokota
Journal:  Cancer Res       Date:  2018-05-16       Impact factor: 12.701

7.  Cystatin D locates in the nucleus at sites of active transcription and modulates gene and protein expression.

Authors:  Gemma Ferrer-Mayorga; Silvia Alvarez-Díaz; Noelia Valle; Javier De Las Rivas; Marta Mendes; Rodrigo Barderas; Francesc Canals; Olga Tapia; J Ignacio Casal; Miguel Lafarga; Alberto Muñoz
Journal:  J Biol Chem       Date:  2015-09-13       Impact factor: 5.157

Review 8.  Osteoimmunology: oncostatin M as a pleiotropic regulator of bone formation and resorption in health and disease.

Authors:  Natalie A Sims; Julian M W Quinn
Journal:  Bonekey Rep       Date:  2014-05-14

9.  BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells.

Authors:  Shaoheng Wan; Yuehong Liu; Yaguang Weng; Wei Wang; Wei Ren; Chang Fei; Yingying Chen; Zhihui Zhang; Ting Wang; Jinshu Wang; Yayun Jiang; Lan Zhou; Tongchuan He; Yan Zhang
Journal:  Cell Oncol (Dordr)       Date:  2014-09-11       Impact factor: 6.730

Review 10.  Molecular mechanisms and clinical management of cancer bone metastasis.

Authors:  Manni Wang; Fan Xia; Yuquan Wei; Xiawei Wei
Journal:  Bone Res       Date:  2020-07-29       Impact factor: 13.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.